Irvine, CaliforniaJanuary 20, 2023 /PRNewswire/ — Seragon Biosciences, Inc. Announces Today the Launch of RESTORIN®, an advanced nutritional food that promotes a healthy aging process. RESTORIN combines a series of patented technologies from Harvard University, Mayo Clinic and Scripps Research to increase cellular nicotinamide adenine dinucleotide (NAD+) levels and enhance senolytic stimulation.
RESTORIN is an advanced Senolytic NAD+ supplement designed to promote a healthy aging process.
[廣告] please read on
For decades, the intricate nature of aging has left scientists with many unanswered questions in the field of aging interventions. Recent research points to Senolytic and NAD+ as key technologies to address this challenge. RESTORIN is a controlled release Senolytic NAD+ supplement. It also utilizes Seragon’s SERC™ Targeted Release Technology, enabling hydrophilic and lipophilic carriers and a pH-responsive enteric delivery system to enhance the bioavailability of ingredients.
RESTORIN contains a series of proprietary forms of Senolytic agents, NAD+ precursor and Sirtuin active complex (STAC). Senolytics are molecules that target senescent cells – senescent cells that promote aging and lead to organ degeneration. NAD+ is a life-sustaining coenzyme that enhances cellular energy metabolism and DNA integrity, and fuels sirtuins, long-lived proteins that are critical to cellular health.
Seragon Senior Scientist David Brown The PhD, who helped develop RESTORIN, said: “There are many studies showing the positive impact of these molecules on aging and aging-related health conditions, but so far no one has been able to combine them in optimal ratios to achieve synergistic effects. We’ve been able to use the best science we have to develop advanced forms of these molecules and a range of complex combinations to fight aging. This is truly a game changer.”
Decades of research have shown that NAD+ levels drop dramatically as we age, increasing our vulnerability to age-related health conditions ranging from diabetes to neurodegeneration. Replenishing NAD+ levels is essential to slow aging. However, effective enhancement of NAD+ at the cellular level through oral delivery has been challenging.
“In the field of aging, a key question to be addressed is how to deliver NAD+ precursors in a way that best promotes cellular NAD+ for healthier aging. We believe RESTORIN achieves best-in-class performance in this regard,” said Dr. Brown , this is truly a breakthrough. It is very exciting to be a part of this development, especially when considering recent studies showing that an increase in NAD+ could even make anti-cancer immunotherapy more effective.”
He added: “It’s exciting to see aging research advance to help people age in a slower, better and healthier way.”
RESTORIN is only available to consumers through its official website at:
about Seragon Biosciences
Seragon Biosciences, Inc., headquartered in Irvine, California, is a research-based biopharmaceutical company dedicated to improving human and animal health through innovative science. Seragon Biosciences is committed to applying cutting-edge scientific and technological advances to the fields of aging, metabolism, gene therapy and bioinformatics. From research to consumer products and clinical applications, Seragon is committed to enabling the most significant breakthroughs in medicine. For more information, please visit: